Suppr超能文献

过氧化物酶体增殖物激活受体β/δ 和 B 细胞淋巴瘤-6 在调节胰腺癌转移和迁移相关基因中的作用。

Role of Peroxisome Proliferator-Activated Receptor β/δ and B-Cell Lymphoma-6 in Regulation of Genes Involved in Metastasis and Migration in Pancreatic Cancer Cells.

机构信息

Department of Veterinary and Biomedical Sciences and Center for Molecular Toxicology and Carcinogenesis, Penn State University, 325 Life Sciences Building, University Park, PA 16802, USA.

出版信息

PPAR Res. 2013;2013:121956. doi: 10.1155/2013/121956. Epub 2013 May 2.

Abstract

PPARβ/δ is a ligand-activated transcription factor that regulates various cellular functions via induction of target genes directly or in concert with its associated transcriptional repressor, BCL-6. Matrix remodeling proteinases are frequently over-expressed in pancreatic cancer and are involved with metastasis. The present study tested the hypothesis that PPARβ/δ is expressed in human pancreatic cancer cells and that its activation could regulate MMP-9, decreasing cancer cells ability to transverse the basement membrane. In human pancreatic cancer tissue there was significantly higher expression of MMP-9 and PPARβ/δ, and lower levels of BCL-6 mRNA. PPARβ/δ activation reduced the TNF α -induced expression of various genes implicated in metastasis and reduced the invasion through a basement membrane in cell culture models. Through the use of short hairpin RNA inhibitors of PPARβ/δ, BCL-6, and MMP-9, it was evident that PPARβ/δ was responsible for the ligand-dependent effects whereas BCL-6 dissociation upon GW501516 treatment was ultimately responsible for decreasing MMP-9 expression and hence invasion activity. These results suggest that PPARβ/δ plays a role in regulating pancreatic cancer cell invasion through regulation of genes via ligand-dependent release of BCL-6 and that activation of the receptor may provide an alternative therapeutic method for controlling migration and metastasis.

摘要

过氧化物酶体增殖物激活受体β/δ(PPARβ/δ)是一种配体激活的转录因子,通过直接诱导靶基因或与相关转录抑制因子 BCL-6 协同作用来调节各种细胞功能。基质重塑蛋白酶在胰腺癌中经常过度表达,并与转移有关。本研究检验了以下假设:PPARβ/δ 在人胰腺癌细胞中表达,其激活可以调节 MMP-9,降低癌细胞穿过基底膜的能力。在人胰腺癌组织中,MMP-9 和 PPARβ/δ 的表达明显升高,而 BCL-6 mRNA 的水平较低。PPARβ/δ 的激活降低了 TNFα 诱导的各种与转移相关基因的表达,并降低了细胞培养模型中穿过基底膜的侵袭。通过使用 PPARβ/δ、BCL-6 和 MMP-9 的短发夹 RNA 抑制剂,显然 PPARβ/δ 负责配体依赖性效应,而 GW501516 处理后 BCL-6 的解离最终负责降低 MMP-9 的表达和侵袭活性。这些结果表明,PPARβ/δ 通过配体依赖性释放 BCL-6 调节基因来调节胰腺癌细胞的侵袭,并且受体的激活可能为控制迁移和转移提供一种替代的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b56b/3659435/181446e4ce38/PPAR2013-121956.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验